These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21479398)

  • 21. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes.
    Chen Y; Qin K; Wu WL; Li G; Zhang J; Du H; Ng MH; Shih JW; Peiris JS; Guan Y; Chen H; Xia N
    J Infect Dis; 2009 Jan; 199(1):49-58. PubMed ID: 19032063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of and immunity to avian influenza A H5 viruses.
    Katz JM; Lu X; Frace AM; Morken T; Zaki SR; Tumpey TM
    Biomed Pharmacother; 2000 May; 54(4):178-87. PubMed ID: 10872716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
    Horimoto T; Takada A; Fujii K; Goto H; Hatta M; Watanabe S; Iwatsuki-Horimoto K; Ito M; Tagawa-Sakai Y; Yamada S; Ito H; Ito T; Imai M; Itamura S; Odagiri T; Tashiro M; Lim W; Guan Y; Peiris M; Kawaoka Y
    Vaccine; 2006 Apr; 24(17):3669-76. PubMed ID: 16378663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and diagnostic application of monoclonal antibodies against influenza virus H5.
    Yang M; Clavijo A; Graham J; Salo T; Hole K; Berhane Y
    J Virol Methods; 2009 Dec; 162(1-2):194-202. PubMed ID: 19699764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.
    Ehrlich HJ; Müller M; Oh HM; Tambyah PA; Joukhadar C; Montomoli E; Fisher D; Berezuk G; Fritsch S; Löw-Baselli A; Vartian N; Bobrovsky R; Pavlova BG; Pöllabauer EM; Kistner O; Barrett PN;
    N Engl J Med; 2008 Jun; 358(24):2573-84. PubMed ID: 18550874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation on the distribution of avian influenza virus in external environment and the level of H5N1 antibody in poultry-exposed population in Wuhan].
    Wang Y; Kong WH; Zhu HH; Luo TY; Lin XM; Yu B; Chen BH; Hu Q; Peng JS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1082-5. PubMed ID: 22336341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.
    Lipatov AS; Hoffmann E; Salomon R; Yen HL; Webster RG
    J Infect Dis; 2006 Oct; 194(8):1040-3. PubMed ID: 16991078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines.
    Kashima Y; Ikeda M; Itoh Y; Sakoda Y; Nagata T; Miyake T; Soda K; Ozaki H; Nakayama M; Shibuya H; Okamatsu M; Ishigaki H; Ishida H; Sawai T; Kawaoka Y; Kida H; Ogasawara K
    Vaccine; 2009 Dec; 27(52):7402-8. PubMed ID: 19747993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of vaccine strains of H5 and H7 influenza viruses.
    Soda K; Sakoda Y; Isoda N; Kajihara M; Haraguchi Y; Shibuya H; Yoshida H; Sasaki T; Sakamoto R; Saijo K; Hagiwara J; Kida H
    Jpn J Vet Res; 2008 Jan; 55(2-3):93-8. PubMed ID: 18318111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
    Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
    Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth inhibition of Staphylococcus aureus and escherichia coli strains by neutralizing IgY antibodies from ostrich egg yolk.
    Tobias FL; Garcia LN; Kanashiro MM; Medina-Acosta E; Brom-de-Luna JG; de Almeida CM; Azevedo Junior RR; Lemos M; Vieira-da-Motta O
    Braz J Microbiol; 2012 Apr; 43(2):544-51. PubMed ID: 24031862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth rate of ostrich (Struthio camelus) chicks under intensive management in Botswana.
    Mushi EZ; Isa JF; Chabo RG; Segaise TT
    Trop Anim Health Prod; 1998 Jun; 30(3):197-203. PubMed ID: 9719849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of the species ostrich (Struthio camelus) and emu (Dromaius novaehollandiae) by polymerase chain reaction using an ostrich-specific primer pair.
    Colombo F; Viacava R; Giaretti M
    Meat Sci; 2000 Sep; 56(1):15-7. PubMed ID: 22061765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphogenesis of the ostrich (
    Raji A; Hashemnia S; Mohammadpoor AA; Nabipour A; Saadatfar Z
    Vet Res Forum; 2024; 15(6):297-301. PubMed ID: 39035480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Breast Cancer Xenograft Model Using the Ostrich Chorioallantoic Membrane-A Proof of Concept.
    Pomraenke M; Bolney R; Winkens T; Perkas O; Pretzel D; Theis B; Greiser J; Freesmeyer M
    Vet Sci; 2023 May; 10(5):. PubMed ID: 37235432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum: Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection.
    Zuo T; Sun J; Wang G; Jiang L; Zuo Y; Li D; Shi X; Liu X; Fan S; Ren H; Hu H; Sun L; Zhou B; Liang M; Zhou P; Wang X; Zhang L
    Nat Commun; 2016 Feb; 7():10757. PubMed ID: 26877249
    [No Abstract]   [Full Text] [Related]  

  • 40. Feathered fears: Could avian H5N1 influenza be the next pandemic threat of disease X?
    Al-Tawfiq JA; Tirupathi R; Temsah MH
    New Microbes New Infect; 2024 Jun; 59():101416. PubMed ID: 38707625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.